Boston Advisors’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-9,817
| Closed | -$1.45M | – | 671 |
|
|
2017
Q4 | $1.45M | Sell |
9,817
-580
| -6% | -$85.8K | 0.03% | 311 |
|
|
2017
Q3 | $1.22M | Buy |
10,397
+60
| +0.6% | +$7.03K | 0.03% | 336 |
|
|
2017
Q2 | $1.34M | Sell |
10,337
-413
| -4% | -$53.6K | 0.03% | 340 |
|
|
2017
Q1 | $1.46M | Sell |
10,750
-2,990
| -22% | -$405K | 0.03% | 311 |
|
|
2016
Q4 | $1.97M | Buy |
13,740
+4,395
| +47% | +$630K | 0.05% | 294 |
|
|
2016
Q3 | $1.1M | Buy |
9,345
+5,650
| +153% | +$667K | 0.03% | 343 |
|
|
2016
Q2 | $391K | Sell |
3,695
-1,210
| -25% | -$128K | 0.01% | 538 |
|
|
2016
Q1 | $547K | Sell |
4,905
-6,135
| -56% | -$684K | 0.01% | 433 |
|
|
2015
Q4 | $1.73M | Sell |
11,040
-1,475
| -12% | -$231K | 0.04% | 276 |
|
|
2015
Q3 | $1.64M | Sell |
12,515
-2,895
| -19% | -$380K | 0.06% | 308 |
|
|
2015
Q2 | $2.68M | Sell |
15,410
-1,810
| -11% | -$315K | 0.11% | 185 |
|
|
2015
Q1 | $2.97M | Buy |
17,220
+1,235
| +8% | +$213K | 0.12% | 189 |
|
|
2014
Q4 | $2.07M | Buy |
15,985
+6,120
| +62% | +$793K | 0.09% | 198 |
|
|
2014
Q3 | $1.27M | Sell |
9,865
-10,955
| -53% | -$1.41M | 0.05% | 252 |
|
|
2014
Q2 | $1.84M | Buy |
20,820
+260
| +1% | +$23K | 0.08% | 220 |
|
|
2014
Q1 | $1.93M | Sell |
20,560
-235
| -1% | -$22.1K | 0.09% | 213 |
|
|
2013
Q4 | $2.35M | Sell |
20,795
-4,030
| -16% | -$456K | 0.11% | 173 |
|
|
2013
Q3 | $1.96M | Buy |
24,825
+11,805
| +91% | +$931K | 0.1% | 182 |
|
|
2013
Q2 | $857K | Buy |
+13,020
| New | +$857K | 0.04% | 261 |
|